VistaGen Therapeutics Inc... (VTGN)
NASDAQ: VTGN
· Real-Time Price · USD
2.62
0.08 (2.95%)
At close: May 20, 2025, 3:59 PM
2.64
0.64%
Pre-market: May 21, 2025, 04:14 AM EDT
VistaGen Therapeutics Revenue Breakdown
| Period Ending | Mar 31, 2022 |
|---|---|
| License Revenue | 1.11M |
| License Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.05M | 4.2M | 4.57M | 4.12M | 3.76M | 3.21M | 2.98M | 3.15M | 3.09M | 3.7M | 4.79M | 4.96M | 3.12M | 3.22M | 2.41M | 1.77M | 2.12M | 1.27M | 1.39M | 1.42M | 2.12M | 1.15M | 1.91M | 3.32M | 1.83M | 2.17M | 1.47M | 1.44M | 988.26K | 2.29M | 1.17M | 5.86M | 1.91M | 1.48M | 1.1M | 7.88M | 1.34M | 3.73M | 1.33M | 2.22M |
| Selling, General, and Administrative Revenue Growth | -3.48% | -8.15% | +10.85% | +9.63% | +17.18% | +7.69% | -5.61% | +2.04% | -16.48% | -22.75% | -3.41% | +59.11% | -3.20% | +33.60% | +36.21% | -16.39% | +66.69% | -8.70% | -2.25% | -32.91% | +85.08% | -40.00% | -42.52% | +81.47% | -15.66% | +48.09% | +1.81% | +45.71% | -56.79% | +96.31% | -80.13% | +207.63% | +29.05% | +34.52% | -86.07% | +490.31% | -64.21% | +181.37% | -40.32% | n/a |
| Research and Development Revenue | 11.3M | 10.21M | 7.65M | 7.44M | 4.54M | 3.85M | 4.2M | 9.34M | 6.85M | 12.89M | 15.29M | 11.77M | 7.78M | 9.94M | 5.46M | 4.89M | 3.5M | 2.36M | 1.73M | 1.84M | 3.01M | 4.21M | 4.31M | 3.76M | 5.34M | 5.26M | 2.74M | 2.64M | 1.6M | 2.43M | 1.1M | 1.16M | 1.61M | 1.61M | 825.7K | 1.1M | 806.3K | 1.66M | 372.6K | 956.1K |
| Research and Development Revenue Growth | +10.67% | +33.56% | +2.84% | +63.89% | +17.83% | -8.24% | -55.05% | +36.23% | -46.85% | -15.67% | +29.91% | +51.29% | -21.70% | +82.08% | +11.58% | +39.90% | +48.25% | +36.22% | -5.94% | -38.94% | -28.31% | -2.52% | +14.79% | -29.56% | +1.41% | +91.75% | +4.01% | +64.68% | -33.99% | +121.36% | -5.57% | -27.94% | +0.31% | +94.51% | -24.70% | +36.00% | -51.31% | +344.47% | -61.03% | n/a |